University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure

Not Applicable

Completed

Conditions: COVID-19
Acute Respiratory Distress Syndrome

Interventions: Biological: Decidual Stromal Cells (DSC)

First Posted Date: 2020-06-30

Last Posted Date: 2024-02-05

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 19

Registration Number: NCT04451291

Locations: 🇨🇦
Brampton Civic Hospital, Brampton, Ontario, Canada
🇨🇦
Etobicoke General Hospital, Etobicoke, Ontario, Canada
🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity

Phase 3

Completed

Conditions: SARS-CoV-2 Infection

Interventions: Other: Placebo
Biological: VPM1002

First Posted Date: 2020-06-19

Last Posted Date: 2022-04-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 122

Registration Number: NCT04439045

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Virtual Assistant for COVID-19 PPE

Not Applicable

Conditions: COVID-19

Interventions: Other: Human Coach first, then Virtual Assistant
Other: Virtual Assistant first, then Human Coach

First Posted Date: 2020-06-17

Last Posted Date: 2021-01-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 50

Registration Number: NCT04435275

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Treatment of Bipolar Depression With Pentoxifylline

Early Phase 1

Completed

Conditions: Bipolar Depression

Interventions: Drug: Pentoxifylline 400 MG

First Posted Date: 2020-06-04

Last Posted Date: 2022-04-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 6

Registration Number: NCT04417049

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Repetitive Transcranial Magnetic Stimulation of the DMPFC for Anorexia and Bulimia: an Open-Label Case Series

Phase 1

Completed

Conditions: Bulimia Nervosa
Anorexia Nervosa

Interventions: Device: Repetitive Transcranial Magnetic Stimulation

First Posted Date: 2020-06-01

Last Posted Date: 2020-06-01

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT04409704

The Açaí Berry COVID-19 Anti-Inflammation Trial

Phase 2

Conditions: COVID

Interventions: Other: Placebo
Dietary Supplement: Açaí palm berry extract - natural product

First Posted Date: 2020-05-27

Last Posted Date: 2022-05-31

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 480

Registration Number: NCT04404218

Locations: 🇧🇷
Instituto de Pesquisas em Saude (IPS)/ Universidade de Caxias do Sul (UCS), Caxias Do Sul, RS, Brazil
🇧🇷
Instituto Prevent Senior (IPS) - Hospital Sancta Maggiore, Sao Paulo, SP, Brazil
🇨🇦
Heart Health Institute Research Inc, Toronto, Ontario, Canada

Erector Spinae Plane (ESP) Block Volunteer Study

Not Applicable

Active, not recruiting

Conditions: Pain Management

Interventions: Other: Erector Spinae Plane Block with 1.5% lidocaine

First Posted Date: 2020-05-26

Last Posted Date: 2024-07-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 24

Registration Number: NCT04401007

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Mental Health Outcomes in Healthcare Workers During COVID-19

Completed

Conditions: PTSD
Depression
Mental Health Wellness 1
Stress
Anxiety
Healthcare Workers
COVID-19

First Posted Date: 2020-05-21

Last Posted Date: 2020-11-03

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 3852

Registration Number: NCT04397848

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

FAZA PET/MRI Pancreas

Not Applicable

Active, not recruiting

Conditions: Locally Advanced Pancreatic Adenocarcinoma
Unresectable Pancreatic Cancer
Pancreatic Adenocarcinoma Non-resectable

First Posted Date: 2020-05-20

Last Posted Date: 2024-06-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT04395469

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)

Phase 1

Completed

Conditions: COVID-19

Interventions: Drug: Nitric Oxide

First Posted Date: 2020-05-11

Last Posted Date: 2022-04-11

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 21

Registration Number: NCT04383002

Locations: 🇨🇦
University Health Network, Toronto General Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy